{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:38Z","timestamp":1786982618698,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["H I13C1474"],"award-info":[{"award-number":["H I13C1474"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s13346-016-0354-3","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T13:46:28Z","timestamp":1483451188000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel route of insulin delivery using an implant-mediated drug delivery system"],"prefix":"10.1007","volume":"7","author":[{"given":"Young-Seok","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"354_CR1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","volume":"378","author":"AA Tahrani","year":"2011","unstructured":"Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011;378:182\u201397.","journal-title":"Lancet"},{"key":"354_CR2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","volume":"383","author":"T Tuomi","year":"2014","unstructured":"Tuomi T et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2014;383:1084\u201394.","journal-title":"Lancet"},{"key":"354_CR3","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-13-0544","volume":"222","author":"H Chen","year":"2014","unstructured":"Chen H, Lan HY, Roukos DH, Cho WC. Application of microRNAs in diabetes mellitus. J Endocrinol. 2014;222:R1\u2013R10.","journal-title":"J Endocrinol"},{"key":"354_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/DMSO.S7315","volume":"3","author":"JP Le Floch","year":"2010","unstructured":"Le Floch JP. Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics. Diabetes Metab Syndr Obes. 2010;3:197\u2013213.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"354_CR5","first-page":"55","volume":"6","author":"MM Aye","year":"2014","unstructured":"Aye MM, Atkin SL. Patient safety and minimizing risk with insulin administration\u2014role of insulin degludec. Drug Healthc Patient Saf. 2014;6:55\u201367.","journal-title":"Drug Healthc Patient Saf"},{"key":"354_CR6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0149-2918(04)90132-4","volume":"26","author":"G Dailey","year":"2004","unstructured":"Dailey G. New strategies for basal insulin treatment in type 2 diabetes mellitus. Clin Ther. 2004;26:889\u2013901.","journal-title":"Clin Ther"},{"key":"354_CR7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.34.3.222","volume":"34","author":"WT Garvey","year":"1985","unstructured":"Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes. 1985;34:222\u201334.","journal-title":"Diabetes"},{"key":"354_CR8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2337\/diab.43.9.1085","volume":"43","author":"RP Robertson","year":"1994","unstructured":"Robertson RP, Olson LK, Zhang HJ. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes. 1994;43:1085\u20139.","journal-title":"Diabetes"},{"key":"354_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2217\/nnm.13.18","volume":"8","author":"L Tomar","year":"2013","unstructured":"Tomar L et al. In vivo evaluation of a conjugated poly (lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model. Int J Nanomedicine. 2013;8:505\u201320.","journal-title":"Int J Nanomedicine"},{"key":"354_CR10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/17425247.2014.917077","volume":"11","author":"AL Smart","year":"2014","unstructured":"Smart AL, Gaisford S, Basit AW. Oral peptide and protein delivery: intestinal obstacles and commercial prospects. Expert Opin Drug Deliv. 2014;11:1323\u201335.","journal-title":"Expert Opin Drug Deliv"},{"key":"354_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2337\/diacare.20.2.176","volume":"20","author":"I Berlin","year":"1997","unstructured":"Berlin I et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care. 1997;20:176\u20138.","journal-title":"Diabetes Care"},{"key":"354_CR12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jps.20848","volume":"96","author":"N Sadrzadeh","year":"2007","unstructured":"Sadrzadeh N, Glembourtt MJ, Stevenson CL. Peptide drug delivery strategies for the treatment of diabetes. J Pharm Sci. 2007;96:1925\u201354.","journal-title":"J Pharm Sci"},{"key":"354_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2004.03.010","volume":"97","author":"Y Onuki","year":"2004","unstructured":"Onuki Y, Morishita M, Takayama K. Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J Control Release. 2004;97:91\u20139.","journal-title":"J Control Release"},{"key":"354_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd836","volume":"1","author":"DR Owens","year":"2002","unstructured":"Owens DR. New horizons\u2014alternative routes for insulin therapy. Nat Rev Drug Discov. 2002;1:529\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"354_CR15","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.biomaterials.2003.11.001","volume":"25","author":"CO Sullivan","year":"2004","unstructured":"Sullivan CO, Birkinshaw C. In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles. Biomaterials. 2004;25:4375\u201382.","journal-title":"Biomaterials"},{"key":"354_CR16","first-page":"801358","volume":"2014","author":"YS Park","year":"2014","unstructured":"Park YS, Cho JY, Lee SJ, Hwang CI. Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system. Biomed Res Int. 2014;2014:801358.","journal-title":"Biomed Res Int"},{"key":"354_CR17","doi-asserted-by":"crossref","first-page":"289614","DOI":"10.1155\/2010\/289614","volume":"2010","author":"J Wang","year":"2010","unstructured":"Wang J et al. Creating a long-term diabetic rabbit model. Exp Diabetes Res. 2010;2010:289614.","journal-title":"Exp Diabetes Res"},{"key":"354_CR18","unstructured":"Team RDC. 2015 R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing."},{"key":"354_CR19","first-page":"1217","volume":"26","author":"YS Park","year":"2011","unstructured":"Park YS, Chang MS, Lee SP. Three-dimensional topography of the gingival line of young adult maxillary teeth: curve averaging using reverse-engineering methods. Int J Oral Maxillofac Implants. 2011;26:1217\u201324.","journal-title":"Int J Oral Maxillofac Implants"},{"key":"354_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jcpe.12073","volume":"40","author":"SH Chung","year":"2013","unstructured":"Chung SH, Kim HK, Shon WJ, Park YS. Peri-implant bone formations around (Ti,Zr) O2-coated zirconia implants with different surface roughness. J Clin Periodontol. 2013;40:404\u201311.","journal-title":"J Clin Periodontol"},{"key":"354_CR21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1600-0501.2012.02468.x","volume":"24","author":"YS Park","year":"2013","unstructured":"Park YS, Chung SH, Shon WJ. Peri-implant bone formation and surface characteristics of rough surface zirconia implants manufactured by powder injection molding technique in rabbit tibiae. Clin Oral Implants Res. 2013;24:586\u201391.","journal-title":"Clin Oral Implants Res"},{"key":"354_CR22","first-page":"1579","volume":"34","author":"D Leveque","year":"2014","unstructured":"Leveque D. Subcutaneous administration of anticancer agents. Anticancer Res. 2014;34:1579\u201386.","journal-title":"Anticancer Res"},{"key":"354_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","volume":"2","author":"PZ Zimmet","year":"2014","unstructured":"Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2:56\u201364.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"354_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","volume":"364","author":"EL McConnell","year":"2008","unstructured":"McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 2008;364:213\u201326.","journal-title":"Int J Pharm"},{"key":"354_CR25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S2213-8587(13)70187-6","volume":"2","author":"KG Alberti","year":"2014","unstructured":"Alberti KG, Zimmet PZ. Diabetes: a look to the future. Lancet Diabetes Endocrinol. 2014;2:e1\u20132.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"354_CR26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1902\/jop.2016.150373","volume":"87","author":"JH Park","year":"2016","unstructured":"Park JH, Cha HS, Kim HK, Park YS. Dexamethasone delivery by an implant-mediated drug delivery system in the canine mandible. J Periodontol. 2016;87:700\u20135.","journal-title":"J Periodontol"},{"key":"354_CR27","doi-asserted-by":"crossref","unstructured":"Cha S, Kim HK, Kho HS, Park YS 2016. The sustained effects of pilocarpine hydrochloride in gelatin hydrogel administered by an implant-mediated drug delivery system. Curr Drug Deliv.","DOI":"10.2174\/1567201813666161013150648"},{"key":"354_CR28","first-page":"e35","volume":"370","author":"SP Dev","year":"2014","unstructured":"Dev SP, Stefan RA, Saun T, Lee S. Videos in clinical medicine. Insertion of an intraosseous needle in adults N Engl J Med. 2014;370:e35.","journal-title":"Insertion of an intraosseous needle in adults N Engl J Med"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0354-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-016-0354-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0354-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:10:55Z","timestamp":1498360255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-016-0354-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1007\/s13346-016-0354-3","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}